APA (7th ed.) Citation

Michael Horn, Ulrich Behre, Magali Traskine, Kurt Dobbelaere, & Dorota Borys. (2021). Safety, reactogenicity, and immunogenicity of a 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine in healthy toddlers: Results from a phase I, randomized trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Michael Horn, Ulrich Behre, Magali Traskine, Kurt Dobbelaere, and Dorota Borys. Safety, Reactogenicity, and Immunogenicity of a 12-valent Pneumococcal Non-typeable Haemophilus Influenzae Protein D-conjugate Vaccine in Healthy Toddlers: Results from a Phase I, Randomized Trial. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Michael Horn, et al. Safety, Reactogenicity, and Immunogenicity of a 12-valent Pneumococcal Non-typeable Haemophilus Influenzae Protein D-conjugate Vaccine in Healthy Toddlers: Results from a Phase I, Randomized Trial. Taylor & Francis Group, 2021.